301130SZSE

Self-Examination Form for the 2026 Restricted Stock Incentive Plan of Jilin Province Xidian Pharmaceutical Technology Development Co., Ltd.

West Point Pharmaceuticals Co., Ltd.·March 20, 2026

✨ AI Summary

This document outlines the self-examination results for the 2026 restricted stock incentive plan of Jilin Province Xidian Pharmaceutical. It confirms compliance with regulatory requirements, including the absence of negative audit opinions and the establishment of a performance evaluation system. Key decisions include the approval of the incentive list by the compensation committee and the plan's adherence to legal stipulations.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Company Abbreviation: Xidian Pharmaceutical

Stock Code: 301130

Independent Financial Advisor: None

Serial Number	Item	Exists (Yes/No/Not Applicable)
1	Has the financial report for the most recent accounting year received a negative opinion or inability to express an opinion from the auditor?	No
2	Has the internal control of the financial report for the most recent accounting year received a negative opinion or inability to express an opinion from the auditor?	No
3	Has there been any instance in the last 36 months of profit distribution not complying with laws, regulations, company articles, or public commitments?	No
4	Are there any other circumstances unsuitable for implementing equity incentives?	No
5	Has a performance evaluation system and evaluation methods been established?	Yes
6	Has any financial assistance, including loans, been provided to the incentive objects?	No

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.